2023 Q2 Form 10-Q Financial Statement

#000149315223016159 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $32.84M $21.67M $9.800M
YoY Change 185.93% 121.1% 339.46%
Cost Of Revenue $20.55M $17.13M $8.214M
YoY Change 115.67% 108.49% 283.83%
Gross Profit $12.29M $4.543M $1.586M
YoY Change 528.05% 186.44% 1486.0%
Gross Profit Margin 37.42% 20.97% 16.18%
Selling, General & Admin $48.09M $31.68M $13.85M
YoY Change 141.0% 128.67% 113.14%
% of Gross Profit 391.29% 697.34% 873.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.659M $3.166M $758.0K
YoY Change 38.86% 317.68% 48.63%
% of Gross Profit 29.77% 69.69% 47.79%
Operating Expenses $52.36M $35.38M $16.63M
YoY Change 118.88% 112.79% 122.3%
Operating Profit -$40.06M -$30.84M -$15.04M
YoY Change 82.42% 105.02% 103.82%
Interest Expense $786.0K $617.0K
YoY Change -272.37%
% of Operating Profit
Other Income/Expense, Net -$1.212M $1.250M -$104.0K
YoY Change 497.04% -1301.92%
Pretax Income -$41.28M -$29.59M -$15.14M
YoY Change 82.47% 95.4% 105.75%
Income Tax $206.0K $212.0K
% Of Pretax Income
Net Earnings -$41.48M -$29.80M -$15.14M
YoY Change 83.38% 96.8% 105.75%
Net Earnings / Revenue -126.31% -137.53% -154.52%
Basic Earnings Per Share -$0.67 -$0.53 -$0.36
Diluted Earnings Per Share -$0.67 -$0.53 -$356.8K
COMMON SHARES
Basic Shares Outstanding 61.17M shares 60.36M shares 42.44M shares
Diluted Shares Outstanding 61.88M shares 56.47M shares 42.44M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.46M $103.2M $162.0M
YoY Change -12.54% -36.29% -30.24%
Cash & Equivalents $74.46M $103.2M $162.0M
Short-Term Investments
Other Short-Term Assets $5.759M $5.211M $576.0K
YoY Change -12.98% 804.69% -52.0%
Inventory $45.36M $39.52M $10.05M
Prepaid Expenses
Receivables $43.44M $27.88M $7.472M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $169.0M $175.8M $180.1M
YoY Change 36.12% -2.37% -24.27%
LONG-TERM ASSETS
Property, Plant & Equipment $31.24M $27.67M $17.83M
YoY Change 21.26% 55.2% 46.11%
Goodwill $232.2M $204.2M
YoY Change 2223590.51%
Intangibles $27.03M $25.07M
YoY Change
Long-Term Investments
YoY Change
Other Assets $686.0K $3.025M $596.0K
YoY Change -66.84% 407.55% 98.67%
Total Long-Term Assets $299.4M $265.2M $41.18M
YoY Change 15.46% 543.91% 192.08%
TOTAL ASSETS
Total Short-Term Assets $169.0M $175.8M $180.1M
Total Long-Term Assets $299.4M $265.2M $41.18M
Total Assets $468.4M $441.0M $221.3M
YoY Change 22.15% 99.31% -12.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.07M $28.62M $8.125M
YoY Change 83.73% 252.26% 162.1%
Accrued Expenses $17.81M $12.81M $7.790M
YoY Change 71.52% 64.42% 199.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.975M $311.0K $10.00K
YoY Change 670.97% 3010.0% -97.5%
Total Short-Term Liabilities $68.54M $55.27M $18.67M
YoY Change 74.08% 196.12% 174.5%
LONG-TERM LIABILITIES
Long-Term Debt $889.0K $321.0K $0.00
YoY Change -100.0%
Other Long-Term Liabilities $386.0K $649.0K $2.513M
YoY Change -99.25% -74.17% 57.06%
Total Long-Term Liabilities $386.0K $649.0K $2.513M
YoY Change -99.25% -74.17% 25.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.54M $55.27M $18.67M
Total Long-Term Liabilities $386.0K $649.0K $2.513M
Total Liabilities $147.9M $107.3M $21.18M
YoY Change 62.66% 406.8% 140.67%
SHAREHOLDERS EQUITY
Retained Earnings -$405.3M -$363.8M
YoY Change
Common Stock $64.00K $60.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $320.6M $333.7M $200.1M
YoY Change
Total Liabilities & Shareholders Equity $468.4M $441.0M $221.3M
YoY Change 22.15% 99.31% -12.16%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$41.48M -$29.80M -$15.14M
YoY Change 83.38% 96.8% 105.75%
Depreciation, Depletion And Amortization $3.659M $3.166M $758.0K
YoY Change 38.86% 317.68% 48.63%
Cash From Operating Activities -$40.86M -$24.18M -$11.38M
YoY Change 108.45% 112.4% 33.92%
INVESTING ACTIVITIES
Capital Expenditures $3.958M $1.665M -$1.368M
YoY Change -550.28% -221.71% -65.97%
Acquisitions
YoY Change
Other Investing Activities -$4.660M
YoY Change -90.68%
Cash From Investing Activities -$8.618M -$2.215M -$1.368M
YoY Change -83.06% 61.92% -96.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.07M $95.36M -77.00K
YoY Change -12556.93% -123944.16% -100.03%
NET CHANGE
Cash From Operating Activities -40.86M -$24.18M -11.38M
Cash From Investing Activities -8.618M -$2.215M -1.368M
Cash From Financing Activities 17.07M $95.36M -77.00K
Net Change In Cash -32.42M $66.65M -12.83M
YoY Change -54.09% -619.54% -107.4%
FREE CASH FLOW
Cash From Operating Activities -$40.86M -$24.18M -$11.38M
Capital Expenditures $3.958M $1.665M -$1.368M
Free Cash Flow -$44.82M -$25.84M -$10.02M
YoY Change 139.38% 158.03% 123.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001429764
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
usd
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 BLNK Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2022Q1 BLNK Change In Fair Value Of Derivative And Other Accrued Liabilities
ChangeInFairValueOfDerivativeAndOtherAccruedLiabilities
usd
CY2022Q1 BLNK Capitalization Of Engineering Costs
CapitalizationOfEngineeringCosts
usd
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
CY2022Q1 BLNK Repayment Of Financing Liability In Connection With Operating Lease
RepaymentOfFinancingLiabilityInConnectionWithOperatingLease
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 BLNK Right Of Use Assets Obtained In Exchange For Lease Liabilities
RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
usd
CY2023Q1 BLNK Intangible Assets Obtained In Exchange For Financing Liability
IntangibleAssetsObtainedInExchangeForFinancingLiability
usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38392
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BLINK CHARGING CO.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0608147
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
605 Lincoln Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33139-3024
CY2023Q1 dei City Area Code
CityAreaCode
(305)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
521-0200
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
BLNK
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61170166 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103202000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36562000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27883000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23581000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
39524000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
34740000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5211000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4399000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
175820000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
99282000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
78000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
71000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27666000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25862000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5095000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4174000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25072000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26582000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
204244000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
203710000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3025000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2861000 usd
CY2023Q1 us-gaap Assets
Assets
441000000 usd
CY2022Q4 us-gaap Assets
Assets
362542000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
28621000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
24585000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12808000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13109000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
10000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
10000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2037000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1738000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
301000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
306000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11496000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10572000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
55273000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50320000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1323000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1316000 usd
CY2023Q1 us-gaap Customer Refund Liability Noncurrent
CustomerRefundLiabilityNoncurrent
40620000 usd
CY2022Q4 us-gaap Customer Refund Liability Noncurrent
CustomerRefundLiabilityNoncurrent
40608000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3744000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3030000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
321000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
408000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
649000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
645000 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5406000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5258000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
107336000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
101585000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60373377 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60373377 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51476445 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51476445 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
60000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
51000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
701331000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
597982000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3896000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3046000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363831000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-334030000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
333664000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260957000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
441000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
362542000 usd
CY2023Q1 us-gaap Revenues
Revenues
21668000 usd
CY2022Q1 us-gaap Revenues
Revenues
9800000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
17125000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
8214000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
4543000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
1586000 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
22709000 usd
CY2022Q1 us-gaap Salaries And Wages
SalariesAndWages
9259000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8478000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4427000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4195000 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2942000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
35382000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
16628000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30839000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-15042000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
617000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
1807000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
3000 usd
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
10000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
50000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-104000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1250000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-101000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29589000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15143000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
212000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-29801000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-15143000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56469928 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42437823 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56469928 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42437823 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-29801000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15143000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
850000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
606000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30651000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15749000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260957000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
260957000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
94766000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
94766000 usd
CY2023Q1 BLNK Stock Issued Common Stock Issued Upon Exercise Of Warrants
StockIssuedCommonStockIssuedUponExerciseOfWarrants
835000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7757000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-850000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-29801000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
333664000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
333664000 usd
CY2023Q1 BLNK Proceeds From Issuance Initial Public Offering Gross
ProceedsFromIssuanceInitialPublicOfferingGross
100000000 usd
CY2023Q1 BLNK Stock Issuance Costs
StockIssuanceCosts
5234000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
213834000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
213834000 usd
CY2022Q1 BLNK Stock Issued Common Stock Issued Upon Exercise Of Warrants
StockIssuedCommonStockIssuedUponExerciseOfWarrants
69000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1933000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-606000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15143000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
200087000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
200087000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-29801000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15143000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3166000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
758000 usd
CY2023Q1 BLNK Noncash Lease Expense
NoncashLeaseExpense
438000 usd
CY2022Q1 BLNK Noncash Lease Expense
NoncashLeaseExpense
55000 usd
CY2023Q1 BLNK Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-8000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
37000 usd
CY2023Q1 BLNK Change In Fair Value Of Derivative And Other Accrued Liabilities
ChangeInFairValueOfDerivativeAndOtherAccruedLiabilities
-10000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
555000 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
502000 usd
CY2023Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
-1701000 usd
CY2022Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
295000 usd
CY2023Q1 BLNK Common Stock Issued For Services And Compensation
CommonStockIssuedForServicesAndCompensation
3685000 usd
CY2022Q1 BLNK Common Stock Issued For Services And Compensation
CommonStockIssuedForServicesAndCompensation
507000 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
4090000 usd
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1455000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
4377000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1722000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3202000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
698000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
590000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-297000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
181000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
288000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3876000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2120000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
101000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-346000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-66000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
226000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
444000 usd
CY2023Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
5624000 usd
CY2022Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3760000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24177000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11383000 usd
CY2023Q1 BLNK Capitalization Of Engineering Costs
CapitalizationOfEngineeringCosts
550000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1665000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1368000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2215000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1368000 usd
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
94766000 usd
CY2023Q1 BLNK Proceeds From Options And Warrant Exercises
ProceedsFromOptionsAndWarrantExercises
835000 usd
CY2022Q1 BLNK Proceeds From Options And Warrant Exercises
ProceedsFromOptionsAndWarrantExercises
69000 usd
CY2023Q1 BLNK Repayment Of Financing Liability In Connection With Operating Lease
RepaymentOfFinancingLiabilityInConnectionWithOperatingLease
92000 usd
CY2023Q1 BLNK Payment Of Financing Liability Of Internal Use Software
PaymentOfFinancingLiabilityOfInternalUseSoftware
149000 usd
CY2022Q1 BLNK Payment Of Financing Liability Of Internal Use Software
PaymentOfFinancingLiabilityOfInternalUseSoftware
146000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95360000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-77000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2321000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-158000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66647000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12986000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36633000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
175049000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103280000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
162063000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103202000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161984000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
78000 usd
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
79000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103280000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
162063000 usd
CY2023Q1 BLNK Proceeds From Issuance Initial Public Offering Gross
ProceedsFromIssuanceInitialPublicOfferingGross
100000000 usd
CY2023Q1 BLNK Deducted Offering Proceeds Cost
DeductedOfferingProceedsCost
5654000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10000 usd
CY2023Q1 BLNK Right Of Use Assets Obtained In Exchange For Lease Liabilities
RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
1209000 usd
CY2022Q1 BLNK Intangible Assets Obtained In Exchange For Financing Liability
IntangibleAssetsObtainedInExchangeForFinancingLiability
660000 usd
CY2023Q1 BLNK Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
-427000 usd
CY2022Q1 BLNK Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
-698000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1807000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000 usd
CY2023Q1 BLNK Other Revenues
OtherRevenues
301000 usd
CY2022Q1 BLNK Other Revenues
OtherRevenues
314000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21668000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9800000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21668000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9800000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16902000 usd
CY2023Q1 BLNK Remaining Performance Obligations For Network Fees
RemainingPerformanceObligationsForNetworkFees
11496000 usd
CY2023Q1 BLNK Revenues Related To Network Fees And Warranty Contracts
RevenuesRelatedToNetworkFeesAndWarrantyContracts
435000 usd
CY2023Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zSRufmm5EDXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_z4yC5T4pck5d">CONCENTRATIONS</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, sales to a significant customer represented <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zSAQYYncbjO7"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_z5KV1vdHzsFk">13%</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of total revenue. During the three months ended March 31, 2022, sales to another significant customer represented <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z5W5WCkmVX4c">12% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of total revenue. During the three months ended March 31, 2023 and 2022, the Company made purchases from a significant supplier that represented <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--SupplierMember_zpHY5p8IDSea">16% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember__srt--MajorCustomersAxis__custom--SupplierMember_zJpKmwiimzk">14% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of total purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2253611 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4235462 shares
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
132000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7632000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y3M14D
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
493000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
168000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
652000 usd
CY2023Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3Y
CY2023Q1 us-gaap Payments For Rent
PaymentsForRent
1020000 usd
CY2023Q1 BLNK Lessee Operating And Finance Lease Description
LesseeOperatingAndFinanceLeaseDescription
the Company did not have additional operating and financing leases that have not yet commenced.
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
10000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
169000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
346000 usd
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
66000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
92000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1209000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y5M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M24D
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055 pure
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047 pure
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.062 pure
CY2022Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.000 pure
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2271000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
340000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1827000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
340000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1297000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
716000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
464000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6575000 usd
CY2023Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
680000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
794000 usd
CY2023Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
58000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
5781000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
622000 usd
CY2023Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
62088000 usd
CY2023Q1 BLNK Repair Deployed Chargers
RepairDeployedChargers
275000 usd

Files In Submission

Name View Source Status
blnk-20230331_lab.xml Edgar Link unprocessable
0001493152-23-016159-index-headers.html Edgar Link pending
0001493152-23-016159-index.html Edgar Link pending
0001493152-23-016159.txt Edgar Link pending
0001493152-23-016159-xbrl.zip Edgar Link pending
blnk-20230331.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
blnk-20230331_cal.xml Edgar Link unprocessable
blnk-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
blnk-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed